Mike Hencke | Director, Investor Relations |
Michel Vounatsos | Chief Executive Officer |
Alfred Sandrock, Jr. | EVP, Research & Development and Chief Medical Officer |
Michael McDonnell | EVP, Chief Financial Officer |
Maxwell Skor | Morgan Stanley |
Terence Flynn | Goldman Sachs |
Marc Goodman | SVB Leerink |
Umer Raffat | Evercore ISI |
Cory Kasimov | JPMorgan |
Evan Seigerman | Credit Suisse |
Michael Yee | Jefferies |
Paul Matteis | Stifel Financial Corp. |
Phil Nadeau | Cowen & Company |
Jay Olson | Oppenheimer |
Robyn Karnauskas | Truist Securities |
Salim Syed | Mizuho Securities |
Good morning. My name is Jake, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Fourth Quarter and Full Year Earnings Call and Financial Update. [Operator Instructions] Thank you. I would now like to turn the conference over to Mr.